{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:10:59Z","timestamp":1790709059000,"version":"4.1.0"},"reference-count":25,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Resection of breast carcinoma with adequate margins reduces the risk of local recurrence and reoperation. Tozuleristide (BLZ-100) is an investigational peptide-fluorophore agent that may aid in intraoperative tumor detection and margin assessment. In this study, fluorescence imaging was conducted ex vivo on gross breast pathology specimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives.\u2014<\/jats:title>\n                    <jats:p>To determine the potential of tozuleristide to detect breast carcinoma in fresh pathology specimens and the feasibility of fluorescence-guided intraoperative pathology assessment of surgical margins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>Twenty-three patients received an intravenous bolus dose of 6 or 12 mg of tozuleristide at least 1 hour before surgery. Fifteen lumpectomy and 12 mastectomy specimens were evaluated for fluorescence by the site's clinical pathology staff using the SIRIS, an investigational near-infrared imaging device. The breast tissue was then processed per usual procedures. Fluorescent patterns were correlated with the corresponding hematoxylin-eosin\u2013stained sections. Clinical pathology reports were used to correlate fluorescent signal to grade, histotype, prognostic marker status, and margin measurements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>Tozuleristide fluorescence was readily observed in invasive and in situ breast carcinoma specimens. Most invasive carcinomas were bright and focal, whereas in situ lesions demonstrated a less intense, more diffuse pattern. Tozuleristide was detected in ductal and lobular carcinomas with a similar fluorescent pattern. Fluorescence was detected in high- and low-grade lesions, and molecular marker\/hormone receptor status did not affect signal. Fluorescence could be used to identify the relationship of carcinoma to margins intraoperatively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Tumor targeting with tozuleristide allowed visual real-time distinction between pathologically confirmed breast carcinoma and normal tissue.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2018-0197-oa","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T12:24:45Z","timestamp":1544790285000},"page":"1076-1083","source":"Crossref","is-referenced-by-count":29,"title":["Real-time Visualization of Breast Carcinoma in Pathology Specimens From Patients Receiving Fluorescent Tumor-Marking Agent Tozuleristide"],"prefix":"10.5858","volume":"143","author":[{"given":"Suzanne M.","family":"Dintzis","sequence":"first","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Hansen","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi M.","family":"Harrington","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart C.","family":"Tan","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis M.","family":"Miller","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ishak","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Parrish-Novak","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kittle","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Perry","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Gombotz","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Fortney","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Porenta","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hales","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine E.","family":"Calhoun","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin O.","family":"Anderson","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara H.","family":"Javid","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Byrd","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Dintzis) and Surgery (Ms Hales and Drs Calhoun, Javid, and Byrd), University of Washington Medical Center, Seattle; Breast Surgery Clinic (Dr Harrington), Department of Pathology (Dr Tan), and Clinical Trials (Mses Fortney and Porenta), Overlake Hospital Medical Center, Bellevue, Washington; Development (Dr Miller), Clinical Operations (Mses Ishak and Gombotz"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2018,12,14]]},"reference":[{"issue":"6","key":"2020081203351444400_i1543-2165-143-9-1076-b01","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.M205662200","article-title":"Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2","volume":"278","author":"Deshane","year":"2003","journal-title":"J Biol Chem"},{"issue":"7","key":"2020081203351444400_i1543-2165-143-9-1076-b02","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1074\/jbc.M109.066092","article-title":"Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects","volume":"285","author":"Kesavan","year":"2010","journal-title":"J Biol Chem"},{"issue":"28","key":"2020081203351444400_i1543-2165-143-9-1076-b03","doi-asserted-by":"crossref","first-page":"25577","DOI":"10.1074\/jbc.M301017200","article-title":"Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin","volume":"278","author":"MacLeod","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"2020081203351444400_i1543-2165-143-9-1076-b04","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/1091581817697685","article-title":"Nonclinical profile of BLZ-100, a tumor-targeting fluorescent imaging agent","volume":"36","author":"Parrish-Novak","year":"2017","journal-title":"Int J Toxicol"},{"key":"2020081203351444400_i1543-2165-143-9-1076-b05","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/2153-3539.96751","article-title":"Review of advanced imaging techniques","volume":"3","author":"Chen","year":"2012","journal-title":"J Pathol Inform"},{"issue":"2","key":"2020081203351444400_i1543-2165-143-9-1076-b06","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/2013.11.FOCUS13497","article-title":"Near-infrared imaging of brain tumors using the Tumor Paint BLZ-100 to achieve near-complete resection of brain tumors","volume":"36","author":"Butte","year":"2014","journal-title":"Neurosurg Focus"},{"issue":"7","key":"2020081203351444400_i1543-2165-143-9-1076-b07","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"issue":"20","key":"2020081203351444400_i1543-2165-143-9-1076-b08","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1158\/0008-5472.CAN-15-0471","article-title":"Preclinical validation of the utility of BLZ-100 in providing fluorescence contrast for imaging spontaneous solid tumors","volume":"75","author":"Fidel","year":"2015","journal-title":"Cancer Res"},{"issue":"4","key":"2020081203351444400_i1543-2165-143-9-1076-b09","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/jamaoto.2015.3617","article-title":"Fluorescence identification of head and neck squamous cell carcinoma and high-risk oral dysplasia with BLZ-100, a chlorotoxin-indocyanine green conjugate","volume":"142","author":"Baik","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"9","key":"2020081203351444400_i1543-2165-143-9-1076-b10","first-page":"e210","article-title":"Fluorescence-guided tumor visualization using the tumor paint BLZ-100","volume":"6","author":"Kittle","year":"2014","journal-title":"Cureus"},{"issue":"4","key":"2020081203351444400_i1543-2165-143-9-1076-b11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1055\/s-0033-1334143","article-title":"Annexin A2 system in human biology: cell surface and beyond","volume":"39","author":"Luo","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"suppl 1","key":"2020081203351444400_i1543-2165-143-9-1076-b12","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.breast.2017.06.029","article-title":"Evaluation of margins in invasive carcinoma and ductal carcinoma in situ: the pathologist's perspective","volume":"34","author":"Schnitt","year":"2017","journal-title":"Breast"},{"key":"2020081203351444400_i1543-2165-143-9-1076-b13","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002439","article-title":"Ductal carcinoma in situ and margins &lt;2 mm: contemporary outcomes with breast conservation","author":"Tadros","year":"2017","journal-title":"Ann Surg"},{"issue":"5","key":"2020081203351444400_i1543-2165-143-9-1076-b14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1245\/s10434-007-9766-0","article-title":"Positive margins: the challenge continues for breast surgeons","volume":"15","author":"Jacobs","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"2020081203351444400_i1543-2165-143-9-1076-b15","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1245\/s10434-009-0609-z","article-title":"Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions","volume":"16","author":"Pleijhuis","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"16","key":"2020081203351444400_i1543-2165-143-9-1076-b16","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1158\/0008-5472.CAN-17-0709","article-title":"Raman-encoded molecular imaging with topically applied SERS nanoparticles for intraoperative guidance of lumpectomy","volume":"77","author":"Wang","year":"2017","journal-title":"Cancer Res"},{"key":"2020081203351444400_i1543-2165-143-9-1076-b17","doi-asserted-by":"crossref","first-page":"21242","DOI":"10.1038\/srep21242","article-title":"Quantitative molecular phenotyping with topically applied SERS nanoparticles for intraoperative guidance of breast cancer lumpectomy","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"2020081203351444400_i1543-2165-143-9-1076-b18","doi-asserted-by":"crossref","first-page":"077006","DOI":"10.1117\/1.3600708","article-title":"Development of a spatially offset Raman spectroscopy probe for breast tumor surgical margin evaluation","volume":"16","author":"Keller","year":"2011","journal-title":"J Biomed Opt"},{"issue":"35","key":"2020081203351444400_i1543-2165-143-9-1076-b19","doi-asserted-by":"crossref","first-page":"12371","DOI":"10.1073\/pnas.0501390102","article-title":"Diagnosing breast cancer by using Raman spectroscopy","volume":"102","author":"Haka","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"2020081203351444400_i1543-2165-143-9-1076-b20","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1088\/0031-9155\/59\/20\/6141","article-title":"Towards intra-operative diagnosis of tumours during breast conserving surgery by selective-sampling Raman micro-spectroscopy","volume":"59","author":"Kong","year":"2014","journal-title":"Phys Med Biol"},{"issue":"22","key":"2020081203351444400_i1543-2165-143-9-1076-b21","doi-asserted-by":"crossref","first-page":"8790","DOI":"10.1158\/0008-5472.CAN-08-4340","article-title":"Intraoperative evaluation of breast tumor margins with optical coherence tomography","volume":"69","author":"Nguyen","year":"2009","journal-title":"Cancer Res"},{"issue":"5","key":"2020081203351444400_i1543-2165-143-9-1076-b22","doi-asserted-by":"crossref","first-page":"056001","DOI":"10.1117\/1.JBO.19.5.056001","article-title":"Detection of breast surgical margins with optical coherence tomography imaging: a concept evaluation study","volume":"19","author":"Savastru","year":"2014","journal-title":"J Biomed Opt"},{"issue":"3","key":"2020081203351444400_i1543-2165-143-9-1076-b23","doi-asserted-by":"crossref","first-page":"34002","DOI":"10.1117\/1.JBO.22.3.034002","article-title":"Evaluation of breast tissue with confocal strip-mosaicking microscopy: a test approach emulating pathology-like examination","volume":"22","author":"Abeytunge","year":"2017","journal-title":"J Biomed Opt"},{"issue":"8","key":"2020081203351444400_i1543-2165-143-9-1076-b24","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1364\/BOE.3.001825","article-title":"Auto-fluorescence lifetime and light reflectance spectroscopy for breast cancer diagnosis: potential tools for intraoperative margin detection","volume":"3","author":"Sharma","year":"2012","journal-title":"Biomed Opt Express"},{"key":"2020081203351444400_i1543-2165-143-9-1076-b25","doi-asserted-by":"crossref","first-page":"718710","DOI":"10.1117\/12.809193","article-title":"A multi-spectral dark-field reflectance microscope for tumor margin delineation during breast lumpectomy","author":"Krishnaswamy","year":"2009","journal-title":"Biomedical Applications of Light Scattering III. Vol 7187"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/143\/9\/1076\/2501490\/arpa_2018-0197-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/143\/9\/1076\/2501490\/arpa_2018-0197-oa.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:36:32Z","timestamp":1764790592000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/143\/9\/article-p1076.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,14]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,12,14]]},"published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2018-0197-oa","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,14]]}}}